NCT07563738
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07563738
Title A 2-part Phase 1/2 Open-label Trial on ODM-212 (TEADCO)
Acronym TEADCO
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Orion Corporation, Orion Pharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.